The hemolysins of Serpulina hyodysenteriae are active at 27 to 40°C and pH 3 to 9 and are unaffected by enzymatic inhibitors. Pore formation was demonstrated by the inhibition of hemolysis with molecules of 2.0 to 2.3 nm in diameter and the release of 86 rubidium from erythrocytes without hemoglobin release after exposure to native hemolysin.
bital-buffered saline (3) to 0.5%. Twofold dilutions of hemolysin were added to an equal amount of 0.5% SRBC. The mixture was incubated at 37°C either for 2 h (native) or overnight (recombinant) and centrifuged at 450 ϫ g for 10 min. Hemoglobin release was measured at a 540-nm wavelength against a buffer control containing SRBC and no hemolysin. The endpoint of the dilution (a hemolytic unit [HU] ) was the highest dilution with 50% lysis. Typical dilution endpoints after native extractions were 1:256 per ml of extract and 1:12 per ml of recombinant extract. Specific activity of the native hemolysin was 4,000 (HU mg Ϫ1 ); that of the recombinant hemolysin was 125 (HU mg Ϫ1 ). Control experiments with extracts of E. coli containing the plasmid without the tlyA insert were tested and found to contain no detectable hemolytic activity. Unless otherwise indicated, native and recombinant hemolysins were used at 30 HU/ml for subsequent experiments.
One-way randomized analysis of variance tests using the CoStat program were run to analyze the values obtained for hemoglobin release at a 540-nm wavelength.
Native or recombinant hemolysin (30 HU/ml) with an equal volume of 0.5% SRBC was incubated with agitation at 4, 10, 27, 37, or 42°C. The assay mixtures were centrifuged, and hemoglobin release was measured. There was no detectable difference between hemoglobin release at 27, 37, and 42°C and the positive controls when either hemolysin was used. Even after 2 h, incubations at 4 and 10°C showed no hemoglobin release. The effects of washing and temperature on the hemolysins and SRBC interaction were also assayed. Either hemolysin (30 HU/ml) was incubated with SRBC for 1 h at 4°C with agitation and then divided into two aliquots. One was washed and resuspended in barbital-buffered saline to original volume. Both aliquots were then incubated at 37°C, centrifuged, and analyzed for hemoglobin release. After a 2-h incubation, the washed portion showed no hemoglobin release while the unwashed portion was entirely lysed. These results indicate that the hemolysins either were not bound or were bound with low affinity at low temperatures to the membrane and could not be reactivated at a higher temperature after washing.
To assess the effect of different pH ranges on protein function, 30 HU of either hemolysin per ml was placed in saline of pH 3, 5, 7, or 9. Equal amounts of 0.5% SRBC were added and incubated. Mixtures were centrifuged, and hemoglobin release was measured. No detectable difference in hemoglobin release was found for any pH value compared to saline controls containing hemolysin and SRBC.
To assess the membrane activity of the S. hyodysenteriae hemolysin, two approaches were initiated. First, to examine enzymatic activity, various enzymatic and phospholipase inhibitors were added to the hemolytic assay mixtures, and the release of hemoglobin from SRBC was determined. Leupeptin (Sigma Chemical Co., St. Louis, Mo.) (final concentration, 10 and 100 M), phenylmethylsulfonyl fluoride (PMSF) (final concentration, 100 nM), EDTA (100 mM), bestatin (40 g/ml), and pepstatin (0.7 g/ml) were tested against 30 HU of native or recombinant hemolysins per ml. Microtiter and tube assays were done to test for the diminution of hemolytic units and hemoglobin release. The protease inhibitors and EDTA were combined with the hemolysin for 10 min before an equal amount of 0.5% SRBC was added and assayed for hemolysin activity. The inhibitors, both individually (Table 1) and collectively (data not shown), were unable to prevent the lysis of erythrocytes by either hemolysin; similarly, there was no decrease in the titer of either of the hemolysins. These results demonstrate that the hemolysins were not lysing cells via a proteolytic and/or enzymatic activity. Control wells containing the protease inhibitors and SRBC without hemolysin did not display any detectable hemoglobin release.
Second, to examine porin activity of the S. hyodysenteriae hemolysin, attempts were made to block the effect of the hemolysin on the membrane by using specifically sized molecules. Polyethylene glycol (PEG) 1000 and PEG 1450 (0.6 M) were added to native or recombinant hemolysin (30 HU/ml) and incubated at 37°C. The mixtures were centrifuged, and the supernatants were measured for hemoglobin release. (2) . The pool of carbohydrates with and without dextran 1500 was added to native (70 HU/ml) or recombinant (30 HU/ml) hemolysin and incubated at 37°C with an equal part of SRBC. After incubation, the mixtures were centrifuged and assayed at 540 nm for hemoglobin release. All assays were compared to controls containing hemolysin and SRBC with no inhibitors added. Mixtures of sugars less than 2.0 and larger than 2.3 nm in diameter (arabinose, raffinose, sucrose, glucose, and dextran 8800) and PEG 1450 were unable to block hemoglobin release to a detectable level ( Table 2) . None of the sugars tested individually were able to significantly block hemoglobin release (data not shown). As the previous data had indicated, molecules such as PEG 1000 (2.0 nm) and dextran 1500 (2.3 nm) were able to block hemolysis of the native hemolysin to a significant degree (P Ͻ 0.01). The results with the recombinant hemolysin were not as clear, in that PEG 1450 was able to block the activity but PEG 1000 was not as efficient at blocking. It is possible that the hemolysin was bound to the PEG or that the PEG was inhibiting the hemoglobin release by disrupting the erythrocyte membrane.
Results from the above experiments suggested that the native hemolysin secreted by the spirochete is a membrane-active cytolysin which lyses erythrocytes osmotically through the formation of pores and that the recombinant hemolysin may act in a similar manner. In order to further substantiate these results, the protocols of Duncan (4) and Madoff et al. (10) were used to examine the release of 86 rubidium ( 86 Rb ϩ ) before the release of hemoglobin through pores in labeled erythrocytes caused by native and recombinant hemolysins.
Leupeptin (100 M), PMSF (100 nM), and EDTA (100 mM) were added to the hemolysins to inactivate extraneous proteolytic enzymes before use in the assay. Fresh bovine erythrocytes were washed and resuspended in PBS containing 0.5% glucose. For each experiment, 40 ml was removed, centrifuged, and resuspended in 1.9 ml of PBS plus 0.5% glucose. 86 Rb ϩ (100 Ci; New England Nuclear Corp., Boston, Mass.) was added to the erythrocytes, and the mixture was incubated for 2 h at 37°C. The cells were washed once and resuspended in 40 ml of PBS plus 0.5% glucose. Aliquots (2 ml) were placed into a 37°C water bath, and at 0, 2, 4, and 5 min, 2 ml of hemolysin (32 HU/ml) or control buffer or 0.2 ml of 1% saponin was added to individual tubes. After 7 min, the tubes were placed in an ice (Table  3 ). In the case of the S. hyodysenteriae native hemolysin, 86 Rb ϩ was released from the cells before hemoglobin; these results further confirm that the native hemolysin lyses the cells by a pore-type mechanism. The recombinant hemolysin was also tested with this protocol, except that the time was expanded from 12 min to 2 h. Recombinant hemolysin (16 HU/ml) was added every half hour, and at 2 h readings were taken. Due to the length of time required for the recombinant hemolysin to lyse the SRBC, no significant values were obtained.
Our results indicate that the native and recombinant hemolysins produced by S. hyodysenteriae are active at a temperature range of 27 to 42°C and are unaffected by leupeptin, PMSF, bestatin, pepstatin, and EDTA. The hemolysin appears to lyse cells via pore formation, as demonstrated by the 86 Rb ϩ release assays in the case of the native hemolysin and by the inhibition of the native and recombinant hemolysins by molecules with diameters of 2.0 to 2.3 nm.
